The upper respiratory tract is from the nose down to the larynx including the sinuses while the lower respiratory tract includes the bronchial tree and the lungs
Risk factors that promote the development of respiratory tract infections
The most critical factor is the quality or condition in the environment
Most preventable infections can be attributed to poor environmental standards such as poor housing conditions, overcrowding, and air pollution both inside and outside the home
1. By person to person which may involve direct spread via droplet nuclei (e.g., sneezing, talking, or coughing resulting in discharge of airborne particles from the respiratory tract of the infected person)
2. Through indirect spread via articles or hands contaminated with the person's infectious secretions
The greatest concentration of the etiologic agent (most commonly due to rhinovirus) is in the nasal secretions and the greatest source of infection is through sneezing, nose blowing, and contamination of external surfaces with nasal secretions
The main cause of the common cold, non enveloped RNA viruses that have more than 100 serologic types, primarily affect the nose and conjunctiva, can withstand adverse environmental conditions and can survive the external environment for many hours but are killed by gastric acid when swallowed
The second most common cause of the common cold, enveloped RNA viruses, infection occurs worldwide and the virus is mainly transmitted by respiratory aerosol, in 2002 a new disease called SARS (Severe Acute Respiratory Syndrome) emerged and coronavirus was implicated as the etiologic agent, the civet cat was identified as the likely reservoir of CoV SARS
A severe form of atypical pneumonia characterized by fever, non productive cough, dyspnea, and hypoxia, chills, rigors, malaise, and headache commonly occur, the incubation period ranges from 2 to 10 days
There is no antiviral therapy or vaccine available for SARS, there have been attempts of using a combination of ribavirin and steroids in the treatment of SARS but the efficacy is still undetermined
Non enveloped DNA viruses that cause a variety of upper and lower respiratory tract diseases such as pharyngitis, conjunctivitis, common cold, and pneumonia, they also cause keratoconjunctivitis, hemorrhagic cystitis, and gastroenteritis
There is no antiviral therapy, live, non attenuated adenovirus vaccine for serotypes 4, 7, and 21 has been developed but was used only by the military and is no longer used now
A common illness of childhood, occurring more commonly during the cold weather months, the most common causes are adenoviruses, frequently causing infection in adolescent and young adults in military training, other viruses that can also cause the disease are influenza and parainfluenza viruses, it is an acute, self limited disease lasting 4 to 10 days
Diagnosis of nasopharyngitis is based on clinical manifestations, management is mainly supportive, the use of throat lozenges, aseptic mouthwash, and decongestants have no role in the management of the infection
Inflammation involving both the pharynx and the tonsils, has a seasonal occurrence and usually involves children 5-10 years of age, with a secondary peak at 12 and 18-20 years of age, the most common cause is Streptococcus pyogenes, it is obtained primarily by direct contact with large droplets or respiratory secretions
Antibiotic treatment is necessary, the drug of choice is penicillin, erythromycin or clindamycin may be given as an alternative for patients allergic to penicillin
Infection that occurs in association with streptococcal pharyngitis and is caused by Streptococcus pyogenes strains producing streptococcal pyrogenic exotoxin or formerly known as erythrogenic toxin, the toxin causes a hypersensitivity reaction producing a pinkish red rash on the skin
The drug of choice is penicillin G, control measures are directed mainly at the human source as the disease is transmitted primarily by inhalation of infective droplets from an infected person
Inflammation of the mucosal lining of one or more of the paranasal sinuses, common in children with allergies, or adenoids and enlarged tonsils, dental infections, and in children with chronic ear infections, the principal pathogens are Haemophilus influenzae and Streptococcus pneumoniae
In young children: persistent rhinorrhea (nasal discharge) with a daytime cough that is worse at night, periorbital edema, post nasal drip, and foul smelling breath
In older children or adults: headaches, dental and facial pain with tenderness over the involved sinuses on palpation
Antimicrobial therapy is done to achieve clinical improvement and sterilization of sinus secretions, it is given for 7 days or more, other measures include: normal saline washes to liquefy secretions and enhance mucociliary transport, use of anti histamines if allergic rhinitis is contributory, corticosteroids to reduce inflammation but must be used with caution because of risk of superinfection, and surgical drainage
Inflammation involving the external ear, the more common cause in tropical countries is Pseudomonas aeruginosa, other causes are Staphylococcus aureus, Proteus vulgaris, Klebsiella, and Escherichia coli, itching and pain are prominent and intense pain is felt when the tragus is pulled, periaural edema and complete obliteration of the canal may be seen in severe infection
Diagnosis is made based on clinical presentation, management includes flushing or irrigation of the external auditory canal with 3% hypertonic saline, if there is no evidence of infection, use of topical corticosteroid cream is sufficient, in the presence of overt infection, Neosporin cream must be applied three times a day, preventive measures include minimizing swimming and exposure to water and minimizing excessive cleaning of the ears
Inflammation of the mucoperiosteallining of the middle ear, two thirds of cases are caused by bacteria with Streptococcus pneumoniae as the most common and Haemophilus influenzae as the second most common cause, viral causes include respiratory syncytial virus, influenza virus, adenovirus, and rhinovirus